Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What lessons can be learnt from withdrawal of mibefradil from the market?

× No keyword cloud information.

13 in total

Review 1. Ion channels and the control of blood pressure.

Authors: E H Baker
Journal: Br J Clin Pharmacol Date: 2000-03 Impact factor: 4.335

Review 2. Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.

Authors: Anne Marie R Yunker
Journal: J Bioenerg Biomembr Date: 2003-12 Impact factor: 2.945

Review 3. Causality assessment of adverse effects: when is re-challenge ethically acceptable?

Authors: A L Po; M J Kendall
Journal: Drug Saf Date: 2001 Impact factor: 5.606

4. Prediction and reverse prediction in therapeutics and toxicology.

Authors: J M Ritter
Journal: Br J Clin Pharmacol Date: 2008-10 Impact factor: 4.335

5. Mibefradil (Ro 40-5967) inhibits several Ca2+ and K+ currents in human fusion-competent myoblasts.

Authors: J H Liu; P Bijlenga; T Occhiodoro; J Fischer-Lougheed; C R Bader; L Bernheim
Journal: Br J Pharmacol Date: 1999-01 Impact factor: 8.739

6. Comparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor.

Authors: Arnulfo Quesada; Peter H Bui; Gregg E Homanics; Oliver Hankinson; Adrian Handforth
Journal: Eur J Pharmacol Date: 2011-01-21 Impact factor: 4.432

7. Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Authors: Matthias Holdhoff; Xiaobu Ye; Jeffrey G Supko; Louis B Nabors; Arati S Desai; Tobias Walbert; Glenn J Lesser; William L Read; Frank S Lieberman; Martin A Lodge; Jeffrey Leal; Joy D Fisher; Serena Desideri; Stuart A Grossman; Richard L Wahl; David Schiff
Journal: Neuro Oncol Date: 2017-06-01 Impact factor: 12.300

8. The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study.

Authors: R M Martin; P Biswas; R D Mann
Journal: Br J Clin Pharmacol Date: 2000-07 Impact factor: 4.335

9. Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model.

Authors: Stephen T Keir; Henry S Friedman; David A Reardon; Darell D Bigner; Lloyd A Gray
Journal: J Neurooncol Date: 2012-10-20 Impact factor: 4.130

10. Adrenergic control mechanisms of heart rate: down to a T?

Authors: G Andre Ng
Journal: J Physiol Date: 2018-03-02 Impact factor: 5.182